Delayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer.

Recruiting N/A Interventional Study
High-risk Prostate Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 and older
Sex
Male
Study type
Interventional
Purpose
Diagnostic
Participants needed
244 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Recent evidence suggests that both standard-time and delayed-time \[⁶⁸Ga\]Ga-PSMA PET acquisitions can reveal clinically relevant findings, and neither phase should be excluded a priori in routine practice. This study evaluates a streamlined dual-phase protocol consisting of: * A standard whole-body PET/CT acquisition performed 60 minutes after radiotracer administration. * A delayed pelvic PET-o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Newly diagnosed prostate cancer undergoing staging, or * Biochemical recurrence following prior radical-intent therapy (surgery and/or radiotherapy), or * High-risk prostate cancer, defined as Gleason Score ≥ 8 or PSA ≥ 20 ng/mL. * Written informed consent and authorization fo…
Contacts

Michela Moscarino, Technician

+390512143179

michela.moscarino@aosp.bo.it

CONTACT